期刊文献+

胃癌病人血清SIL—2R和外周血CD_4/CD_8的相关研究 被引量:2

Association Between SIL-2R and T-lympbocyte Subsets in Patients with Gastric Cancer
暂未订购
导出
摘要 分别应用双抗体夹心法和流式细胞术测定52例胃癌病人的血清可溶性白细胞介素2受体(Soluble inter-leukin2 receptor,SLI-2R)和外周血CD_4/CD_8,结果胃癌病人SIL-2R明显升高,CD_4/CD_8明显降低(均P<0.01),且临床分期越高越明显,两者之间存在明显的负相关关系(r=-0.87),提示胃癌病人细胞免疫功能抑制。 Using by sandwich ELISA with monoclonal and polyclonal antibodies and cytometry analy-sis techniques. The serum soluble interleukin 2 receptor (SIL-2R) and CD4/CD8 are measured in 52 pa-tients with gastric cancer. The results show the level of SIL-2R is obvious higher than that of the healthy controls. CD4/CD8 is marked lower than that of normal group (P<0.01). There is a close negative corre-lation between SIL-2R and CD4/CD8(r =- 0.87). Those results indicate that the measurement of SIL-2R and CD4/CD8 may be a important parameter for estimating of degree of seriousness and prognosis of gastric cancer.
出处 《临床消化病杂志》 1999年第1期5-6,共2页 Chinese Journal of Clinical Gastroenterology
关键词 胃肿瘤 T淋巴细胞亚群 SIL-2R Stomach neoplasmas Soluble interleukin 2 receptor T lymphocyte subsets
  • 相关文献

参考文献3

二级参考文献6

  • 1石学耕,上海第二医科大学学报,1993年,13卷,254页
  • 2孙永菊,中华耳鼻咽喉科杂志,1992年,27卷,45页
  • 3王振义,临床诊断学,1991年
  • 4Guo Yangchun,Otolaryngol Head Neck Surg,1993年,100卷,95页
  • 5富宁,朱迅.白血病患者血清IL-2可溶性受体检测初报[J]中国免疫学杂志,1988(05).
  • 6富宁,朱迅,杨贵贞.可溶性白细胞介素2受体及其生物学意义[J].国外医学(免疫学分册),1989,12(5):225-228. 被引量:140

共引文献147

同被引文献17

  • 1周志强,刘为纹,陈文生,孙贵银,房殿春.白细胞介素-2基因转导人胃癌细胞的实验研究[J].中华内科杂志,1997,36(4):225-227. 被引量:7
  • 2Tadatsugu t,Yasuhiro m.The IL-IL-2 Receptor system:a current overview[J].Cell,1993;73(1)∶5-8.
  • 3Wang YF,Wu XN,Zhou YH,et al.Clinical significance of elevated serum soluble interleukin 2 receptor in gastric cancer[J].Chin Med J Engl,1994;107(4)∶254-256.
  • 4Rubin LA,Kurman CC,Fritz ME,et al.Soluble interleukin 2 receptors are released by activated human lymphoid cells in vitro[J].J Immunol,1985;135(5)∶3172-3176.
  • 5Semenzato BG,Foa R,Agostini C,et al.High serum levels of solubie interleukin 2 receptor in patients with 13 chronic lymphocytic leukemia[J].Blood,1987;70(2)∶396-400.
  • 6Buccheri G,Marino P,Preatoni A,et al.Soluble interleukin 2 receptor in lung cancer.An indirect marker of tumor activity[J]?Chest,1991;99(6)∶1433-1437.
  • 7Burton DP,Blanckard DK,Michelini NB,et al.High serum and ascitic soluble interleukin 2 receptor alpha levels in advanced epithelial ovarian cancer[J].Blood,1993;81(2)∶424-429.
  • 8Tartour E,Deneux L,Mosseri V,et al.Soluble interleukin 2 receptor serum levle as a predictor of locoregional control and survival for patients with head and neck carcinoma[J].Cancer,1997;79(7)∶1401-1408.
  • 9Murakami S.Satomi A,Ishida K,et al.Serum Soluble interleukin 2 receptor concentrations in patients with gastric cancer[J].Cancer,1994;74(10)∶2745-2748.[10]Nakata B,Hirakawa K,Kato Y,et al.Serum soluble interleukin 2 receptor level as a prognostic indicator in gastric cancer[J].Br J Cancer,1998;77(11)∶1820-1824.
  • 10Marino P,Cuguo M,Preatoni A,et al.Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer[J].Br J Cancer,1990;61(3)∶434-435.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部